⌘K

Login Start Free

Home/Filings/4/0001144204-18-000497

4//SEC Filing

Wirostko Barbara 4

Accession 0001144204-18-000497

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:07 PM ET

Size

4.8 KB

Accession

0001144204-18-000497

Insider Transaction Report

Form 4

Period: 2017-12-29

EYEGATE PHARMACEUTICALS INCEYEG

Wirostko Barbara

Chief Medical Officer

Transactions

Other
Common Stock
2017-12-29$1.01/sh+12,355$12,479→ 240,397 total

Footnotes (1)

[F1]The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c).

Documents

1 file

4
tv482538_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001669087

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:07 PM ET
Size: 4.8 KB

View on SEC.gov